252 related articles for article (PubMed ID: 28420650)
41. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
Mitro N; Vargas L; Romeo R; Koder A; Saez E
FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of notch enhances the anti-atherosclerotic effects of LXR agonists while reducing fatty liver development in ApoE-deficient mice.
Hao Y; Wang X; Zhang F; Wang M; Wang Y; Wang H; Du Y; Wang T; Fu F; Gao Z; Zhang L
Toxicol Appl Pharmacol; 2020 Nov; 406():115211. PubMed ID: 32853627
[TBL] [Abstract][Full Text] [Related]
43. Activation of LXRα induces lipogenesis in HaCaT cells.
Hong I; Rho HS; Kim DH; Lee MO
Arch Pharm Res; 2010 Sep; 33(9):1443-9. PubMed ID: 20945144
[TBL] [Abstract][Full Text] [Related]
44. CCAAT/enhancer binding protein β deletion increases mitochondrial function and protects mice from LXR-induced hepatic steatosis.
Rahman SM; Choudhury M; Janssen RC; Baquero KC; Miyazaki M; Friedman JE
Biochem Biophys Res Commun; 2013 Jan; 430(1):336-9. PubMed ID: 23159614
[TBL] [Abstract][Full Text] [Related]
45. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
46. Reduction of Hepatic Lipogenesis by Loliolide and Pinoresinol from
Kim SY; Lee JY; Jhin C; Shin JM; Kim M; Ahn HR; Yoo G; Son YJ; Jung SH; Nho CW
J Agric Food Chem; 2019 Nov; 67(45):12419-12427. PubMed ID: 31610126
[TBL] [Abstract][Full Text] [Related]
47. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
Gao M; Bu L; Ma Y; Liu D
PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
[TBL] [Abstract][Full Text] [Related]
48. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
49. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
Kim JH; Jung DY; Kim HR; Jung MH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism.
van Straten EM; Huijkman NC; Baller JF; Kuipers F; Plösch T
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1341-8. PubMed ID: 18840761
[TBL] [Abstract][Full Text] [Related]
51. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
[TBL] [Abstract][Full Text] [Related]
52. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
[TBL] [Abstract][Full Text] [Related]
53. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.
Shrestha E; Hussein MA; Savas JN; Ouimet M; Barrett TJ; Leone S; Yates JR; Moore KJ; Fisher EA; Garabedian MJ
J Biol Chem; 2016 May; 291(21):11172-84. PubMed ID: 27026705
[TBL] [Abstract][Full Text] [Related]
54. A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation.
Hijmans BS; Tiemann CA; Grefhorst A; Boesjes M; van Dijk TH; Tietge UJ; Kuipers F; van Riel NA; Groen AK; Oosterveer MH
FASEB J; 2015 Apr; 29(4):1153-64. PubMed ID: 25477282
[TBL] [Abstract][Full Text] [Related]
55. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
[TBL] [Abstract][Full Text] [Related]
56. Impairment of trophoblast survival and differentiation by LXR ligands is prevented by cholesterol but not ABCA1 silencing.
Harmon CM; McGonigal S; Larkin JC
Placenta; 2018 Sep; 69():50-56. PubMed ID: 30213484
[TBL] [Abstract][Full Text] [Related]
57. Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.
Su W; Peng J; Li S; Dai YB; Wang CJ; Xu H; Gao M; Ruan XZ; Gustafsson JÅ; Guan YF; Zhang XY
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E357-E367. PubMed ID: 28270440
[TBL] [Abstract][Full Text] [Related]
58. Liver X receptors regulate cholesterol homeostasis in oligodendrocytes.
Nelissen K; Mulder M; Smets I; Timmermans S; Smeets K; Ameloot M; Hendriks JJ
J Neurosci Res; 2012 Jan; 90(1):60-71. PubMed ID: 21972082
[TBL] [Abstract][Full Text] [Related]
59. Hepatic oleate regulates adipose tissue lipogenesis and fatty acid oxidation.
Burhans MS; Flowers MT; Harrington KR; Bond LM; Guo CA; Anderson RM; Ntambi JM
J Lipid Res; 2015 Feb; 56(2):304-18. PubMed ID: 25555387
[TBL] [Abstract][Full Text] [Related]
60. The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells.
Xu Y; Hernández-Ledezma JJ; Hutchison SM; Bogan RL
Mol Cell Endocrinol; 2018 Sep; 473():124-135. PubMed ID: 29366778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]